Biowaiver monographs for immediate release solid oral dosage forms: Ciprofloxacin hydrochloride | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba | |
| dc.conicet.organizacion | Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia | |
| dc.conicet.organizacion | Naresuan University | |
| dc.conicet.organizacion | University of Saskatchewan | |
| dc.conicet.organizacion | International Pharmaceutical Federation | |
| dc.conicet.organizacion | University of Texas at Austin. Oden Institute for Computational Engineering and Sciences | |
| dc.conicet.organizacion | Goethe Universitat Frankfurt | |
| dc.conicet.organizacion | National Institute for Public Health and the Environment | |
| dc.contributor.author | Olivera, Maria Eugenia | |
| dc.contributor.author | Manzo, Ruben Hilario | |
| dc.contributor.author | Junginger, H. E. | |
| dc.contributor.author | Midha, K. K. | |
| dc.contributor.author | Shah, V. P. | |
| dc.contributor.author | Stavchansky, S | |
| dc.contributor.author | Dressman, J.B. | |
| dc.contributor.author | D.M. Barends. | |
| dc.date.issued | 2011-01 | |
| dc.description.abstract | Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage forms containing ciprofloxacin hydrochloride as the only active pharmaceutical ingredient (API) are reviewed. Ciprofloxacin hydrochloride's solubility and permeability, its therapeutic use and index, pharmacokinetics, excipient interactions and reported BE/bioavailability (BA) problems were taken into consideration. Solubility and BA data indicate that ciprofloxacin hydrochloride is a BCS Class IV drug. Therefore, a biowaiver based approval of ciprofloxacin hydrochloride containing IR solid oral dosage forms cannot be recommended for either new multisource drug products or for major scale-up and postapproval changes (variations) to existing drug products. | es |
| dc.description.fil | Fil: Olivera, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina | |
| dc.description.fil | Fil: Manzo, Ruben Hilario. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina | |
| dc.description.fil | Fil: Junginger, H. E.. Naresuan University; Tailandia | |
| dc.description.fil | Fil: Midha, K. K.. University of Saskatchewan; Canadá | |
| dc.description.fil | Fil: Shah, V. P.. International Pharmaceutical Federation; Países Bajos | |
| dc.description.fil | Fil: Stavchansky, S. University of Texas at Austin. Oden Institute for Computational Engineering and Sciences; Estados Unidos | |
| dc.description.fil | Fil: Dressman, J.B.. Goethe Universitat Frankfurt; Alemania | |
| dc.description.fil | Fil: D.M. Barends.. National Institute for Public Health and the Environment; Países Bajos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Olivera, Maria Eugenia; Manzo, Ruben Hilario; Junginger, H. E.; Midha, K. K.; Shah, V. P.; et al.; Biowaiver monographs for immediate release solid oral dosage forms: Ciprofloxacin hydrochloride; John Wiley & Sons Inc; Journal of Pharmaceutical Sciences; 100; 1; 1-2011; 22-33 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0022-3549 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/131969 | |
| dc.journal.ciudad | Hoboken | es |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 22-33 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Journal of Pharmaceutical Sciences | es |
| dc.journal.volume | 100 | es |
| dc.language.iso | eng | es |
| dc.publisher | John Wiley & Sons Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://jpharmsci.org/article/S0022-3549(15)32338-8/fulltext | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1002/jps.22259 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | ABSORPTION | es |
| dc.subject | BIOPHARMACEUTICS CLASSIFICATION SYSTEM (BCS) | es |
| dc.subject | CIPROFLOXACIN | es |
| dc.subject | DISSOLUTION | es |
| dc.subject | PERMEABILITY | es |
| dc.subject | REGULATORY SCIENCE | es |
| dc.subject | SOLUBILITY | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Biowaiver monographs for immediate release solid oral dosage forms: Ciprofloxacin hydrochloride | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.ab0a985f-358c-406d-a9b2-153af858eb7c_A.pdf
- Tamaño:
- 148.64 KB
- Formato:
- Adobe Portable Document Format
- Descripción: